Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,315 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nationwide effectiveness of five SARS-CoV-2 vaccines in Hungary-the HUN-VE study.
Vokó Z, Kiss Z, Surján G, Surján O, Barcza Z, Pályi B, Formanek-Balku E, Molnár GA, Herczeg R, Gyenesei A, Miseta A, Kollár L, Wittmann I, Müller C, Kásler M. Vokó Z, et al. Among authors: muller c. Clin Microbiol Infect. 2022 Mar;28(3):398-404. doi: 10.1016/j.cmi.2021.11.011. Epub 2021 Nov 25. Clin Microbiol Infect. 2022. PMID: 34838783 Free PMC article.
Booster Vaccination Decreases 28-Day All-Cause Mortality of the Elderly Hospitalized Due to SARS-CoV-2 Delta Variant.
Müller V, Polivka L, Valyi-Nagy I, Nagy A, Szekanecz Z, Bogos K, Vago H, Kamondi A, Fekete F, Szlavik J, Elek J, Surján G, Surján O, Nagy P, Schaff Z, Müller C, Kiss Z, Kásler M. Müller V, et al. Among authors: muller c. Vaccines (Basel). 2022 Jun 21;10(7):986. doi: 10.3390/vaccines10070986. Vaccines (Basel). 2022. PMID: 35891151 Free PMC article.
Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study).
Vokó Z, Kiss Z, Surján G, Surján O, Barcza Z, Wittmann I, Molnár GA, Nagy D, Müller V, Bogos K, Nagy P, Kenessey I, Wéber A, Polivka L, Pálosi M, Szlávik J, Rokszin G, Müller C, Szekanecz Z, Kásler M. Vokó Z, et al. Among authors: muller v, muller c. Front Immunol. 2022 Jul 22;13:919408. doi: 10.3389/fimmu.2022.919408. eCollection 2022. Front Immunol. 2022. PMID: 35935993 Free PMC article.
Nationwide Effectiveness of First and Second SARS-CoV2 Booster Vaccines During the Delta and Omicron Pandemic Waves in Hungary (HUN-VE 2 Study).
Kiss Z, Wittmann I, Polivka L, Surján G, Surján O, Barcza Z, Molnár GA, Nagy D, Müller V, Bogos K, Nagy P, Kenessey I, Wéber A, Pálosi M, Szlávik J, Schaff Z, Szekanecz Z, Müller C, Kásler M, Vokó Z. Kiss Z, et al. Among authors: muller v, muller c. Front Immunol. 2022 Jun 23;13:905585. doi: 10.3389/fimmu.2022.905585. eCollection 2022. Front Immunol. 2022. PMID: 35812442 Free PMC article.
Waning of SARS-CoV-2 Vaccine Effectiveness in COPD Patients: Lessons from the Delta Variant.
Polivka L, Valyi-Nagy I, Szekanecz Z, Bogos K, Vago H, Kamondi A, Fekete F, Szlavik J, Surjan G, Surjan O, Nagy P, Schaff Z, Kiss Z, Müller C, Kasler M, Müller V. Polivka L, et al. Among authors: muller v, muller c. Vaccines (Basel). 2023 Nov 29;11(12):1786. doi: 10.3390/vaccines11121786. Vaccines (Basel). 2023. PMID: 38140190 Free PMC article.
Effectiveness of SARS-CoV-2 primary vaccines and boosters in patients with type 2 diabetes mellitus in Hungary (HUN-VE 4 Study).
Molnár GA, Vokó Z, Sütő G, Rokszin G, Nagy D, Surján G, Surján O, Nagy P, Kenessey I, Wéber A, Pálosi M, Müller C, Kásler M, Wittmann I, Kiss Z. Molnár GA, et al. Among authors: muller c. BMJ Open Diabetes Res Care. 2024 Jan 24;12(1):e003777. doi: 10.1136/bmjdrc-2023-003777. BMJ Open Diabetes Res Care. 2024. PMID: 38267204 Free PMC article.
7,315 results